The 20-year-old company’s first product tackles certain breast cancers.
Image: Dr. Scott Koenig is president and CEO of Rockville biotech MacroGenics. JOANNE S. LAWTON
{iframe}https://www.bizjournals.com/washington/news/2020/12/16/macrogenics-wins-fda-approval-for-first-product.html{/iframe}